| Zhang, Feng Xi |
NCT04300114: A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy |
|
|
| Terminated | 3 | 5 | RoW | Fluzoparib, SHR3162, Placebo | Jiangsu HengRui Medicine Co., Ltd. | Metastatic Pancreatic Cancer | 02/22 | 02/22 | | |
NCT06004856: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia |
|
|
| Recruiting | 3 | 195 | RoW | Orelabrutinib, Placebo | Beijing InnoCare Pharma Tech Co., Ltd. | Chronic Primary Immune Thrombocytopenia (ITP) | 12/25 | 04/26 | | |
NCT06057571: Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor |
|
|
| Recruiting | 2 | 50 | RoW | TT-00420 (tinengotinib) | TransThera Sciences (Nanjing), Inc. | Cholangiocarcinoma Metastatic | 06/25 | 10/25 | | |
| Recruiting | 1/2 | 380 | RoW | PM8002 | Biotheus Inc. | Malignant Neoplasm | 11/25 | 11/25 | | |
| Recruiting | 1 | 34 | RoW | TQB2223 injection, Penpulimab Injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Hepatocellular Carcinoma | 02/25 | 10/25 | | |
NCT04179045: A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System |
|
|
| Not yet recruiting | N/A | 785 | RoW | The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System | Shanghai Bio-heart Biological Technology Co., Ltd., CCRF Inc., Beijing, China | Coronary Artery Disease | 07/22 | 07/26 | | |
NCT06196242: Deep Brain Stimulation Lead Localization After Implantation |
|
|
| Recruiting | N/A | 10 | RoW | MRI and CT scan | Tsinghua University | Parkinson Disease | 12/24 | 12/25 | | |
NCT06013670: Standard Therapy and TIPS for Moderate to High-risk Esophageal and Gastric Variceal Bleeding |
|
|
| Recruiting | N/A | 86 | RoW | Endoscopy+NSBBs, Transjugular intrahepatic portosystemic shunt | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanfang Hospital, Southern Medical University, Beijing Friendship Hospital | Portal Hypertension | 05/26 | 05/26 | | |
